Probing the nanoparticle-AGO2 interaction for enhanced gene knockdown

Area of Science:

• Biotechnology
• Molecular Biology
• Nanomedicine

Background:

• RNA interference (RNAi) offers therapeutic potential by silencing specific genes.
• Nanoparticle formulations are widely explored for delivering small interfering RNA (siRNA).
• Focus has been on endosomal escape, with less attention on nanoparticle interaction with the RNA-induced silencing complex (RISC).

Purpose of the Study:

• To investigate the impact of nanoparticle steric hindrance on RISC interaction.
• To correlate nanoparticle size and hardness with gene knockdown efficiency.
• To optimize nanoparticle design for enhanced RNAi therapeutic efficacy.

Main Methods:

• Systematic probing of nanoparticle size and hardness effects on RISC interaction.
• Development of an in vitro assay to quantify nanoparticle-RISC interaction.
• Correlation of RISC interaction with gene knockdown efficiency in cancer cells.

Main Results:

• Nanoparticle size and hardness significantly influence RISC interaction.
• Soft and small nanoparticles demonstrated superior RISC interaction.
• Optimized nanoparticles showed enhanced gene knockdown of polo-like-kinase 1 (PLK1).

Conclusions:

• Nanoparticle properties, specifically size and softness, are critical for effective RISC engagement.
• Soft, small nanoparticles represent a promising strategy for improving RNAi-based therapies.
• This study provides insights into optimizing nanoparticle design for enhanced gene silencing efficacy.